BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22135319)

  • 1. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study.
    Russo V; Rago A; Politano L; Della Cioppa N; Russo MG; Golino P; Calabrò R; Nigro G
    Europace; 2012 Apr; 14(4):486-9. PubMed ID: 22135319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study.
    Nigro G; Russo V; Rago A; Antonio Papa A; Palladino A; Politano L
    Acta Myol; 2012 Oct; 31(2):139-43. PubMed ID: 23097606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population.
    Russo V; Nigro G; DI Meo F; Papa AA; Cioppa ND; Proietti R; Russo MG; Calabrò R; Politano L
    Acta Myol; 2014 Dec; 33(3):127-35. PubMed ID: 25873781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?
    Russo V; Rago A; Papa AA; Politano L; Golino P; Russo MG; Calabrò R; Nigro G
    Kardiol Pol; 2013; 71(11):1147-53. PubMed ID: 24297712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study.
    Russo V; Papa AA; Rago A; Ciardiello C; Nigro G
    Heart Rhythm; 2018 Jul; 15(7):962-968. PubMed ID: 29524476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study.
    Nigro G; Russo V; Politano L; Della Cioppa N; Rago A; Arena G; Papa AA; Paoli LD; de Chiara A; Russo MG; Golino P; Calabrò R
    Europace; 2010 Sep; 12(9):1219-23. PubMed ID: 20538830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septal atrial pacing for the prevention of atrial fibrillation.
    Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
    Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination].
    Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
    Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
    Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up.
    Russo V; Nigro G; Rago A; Antonio Papa A; Proietti R; Della Cioppa N; Cristiano A; Palladino A; Calabrò R; Politano L
    Acta Myol; 2013 Dec; 32(3):142-7. PubMed ID: 24803841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preliminary study on the role of anti-atrial fibrillation pacemaker in the prevention of atrial tachyarrhythmia].
    Yang JF; Tong JB; Wang ZL; Zhou T; Li M; Wu SJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):824-6. PubMed ID: 16266459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of atrial fibrillation: does the atrial lead position influence the incidence of atrial arrhythmias in patients with sinus node dysfunction? Results from the PASTA Trial.
    Spitzer SG; Wacker P; Gazarek S; Malinowski K; Schibgilla V;
    Pacing Clin Electrophysiol; 2009 Dec; 32(12):1553-61. PubMed ID: 19793371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
    Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L;
    Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.